BPC-157 vs BPC-157 + TB-500 blend

Name: BPC-157 vs BPC-157 + TB-500 blend
Published: 2026-10-24

Updated Oct 24, 20267 sources

Key differences

1Separate BPC-157 can go near the injury daily. In the blend, every draw also carries TB-500.

Facts from each record, in the same words as their own pages.

BPC-157 and BPC-157 + TB-500 blend side by side
	BPC-157	BPC-157 + TB-500 blend
Category	Healing & recovery	Healing & recovery
Evidence	Limited human data	No human trials
FDA status	Not FDA approvedRegulatory	Not FDA approvedRegulatory
WADA	Prohibited	Prohibited
Half-life	Under 30 minutes for the intact peptide in rats and dogs. No human data. The 4-hour figure on many sites has no primary source.Competitor guide	No value for the blend. BPC-157 clears in under 30 minutes in rats and dogs. The TB-500 fragment has no human value; full-length thymosin beta-4 by IV lasted longer at higher doses.Competitor guide
Routes	Subcutaneous injection, Oral	Subcutaneous injection
Forms	Vial (powder), Capsule, Tablet	Vial (powder)
Reported doses	100 to 750 mcg (subcutaneous injection) 1.6 to 10 mcg/kg (subcutaneous injection) 250 to 1,000 mcg (oral)	250 to 1,500 mcg (subcutaneous injection) 0.5 to 2 mg (subcutaneous injection)
Most cited frequency	Once daily	Once daily
Vial sizes	5 mg, 10 mg, 20 mg, 30 mg, 40 mgCompetitor guide	10 mg, 20 mgCompetitor guide
Mixed vial keeps	Fridge at 2 to 8 C, dark, never frozen.Competitor guide	Fridge at 2 to 8 C, never frozen.Competitor guide
Protocols on file	23	8

Doses shown are what sources report, labelled by origin. Not medical advice.

7 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.